C5orf32 Activators
C5orf32 is a protein that may be activated by a variety of biochemical mechanisms, primarily hinging upon the modulation of intracellular cyclic nucleotide levels. Compounds that enhance adenylate cyclase activity, leading to increased concentrations of cAMP, are particularly relevant to this protein's activation. Such elevation in cAMP levels can activate protein kinase A, a key kinase in numerous signaling pathways, which in turn has the potential to phosphorylate an array of downstream targets, including C5orf32. Similarly, agents that prevent the degradation of cAMP by inhibiting phosphodiesterases also contribute to sustained intracellular cAMP concentrations, again facilitating the activation of protein kinase A. The phosphorylation cascade initiated by this kinase could conceivably result in the activation of C5orf32, thereby impacting its function in cellular processes. Additionally, certain neurotransmitters and hormones that bind to and activate G protein-coupled receptors may increase cAMP levels via receptor-mediated signaling, further potentiating the activation of C5orf32 through these pathways.
Moreover, other activators operate by influencing different components of cellular signaling. Some compounds can directly enhance the production of second messengers, such as cGMP, which may have a secondary effect on cAMP pathways and lead to the activation of C5orf32. Certain activators of stress-activated protein kinases caninduce phosphorylation events that might be implicated in the activation of C5orf32 as part of cellular stress response mechanisms. Furthermore, the influence of exotoxins that lock specific enzymes in an active state results in an upsurge of secondary messenger levels, which subsequently can lead to the activation of C5orf32 through kinase-driven phosphorylation pathways.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Isoproterenol Hydrochloride | 51-30-9 | sc-202188 sc-202188A | 100 mg 500 mg | $28.00 $38.00 | 5 | |
A synthetic catecholamine and beta-adrenergic agonist that elevates intracellular cAMP levels through G protein-coupled receptor signaling, possibly leading to enhanced C5orf32 activity via the cAMP-dependent PKA pathway. | ||||||
IBMX | 28822-58-4 | sc-201188 sc-201188B sc-201188A | 200 mg 500 mg 1 g | $260.00 $350.00 $500.00 | 34 | |
A non-selective inhibitor of phosphodiesterases, IBMX increases intracellular cAMP and cGMP by preventing their degradation. Increased cAMP levels may activate PKA, which could in turn activate C5orf32 via phosphorylation. | ||||||
Sodium Fluoride | 7681-49-4 | sc-24988A sc-24988 sc-24988B | 5 g 100 g 500 g | $40.00 $46.00 $100.00 | 26 | |
An allosteric activator of adenylate cyclase, sodium fluoride increases intracellular cAMP levels. The subsequent activation of PKA could lead to phosphorylation events that activate C5orf32. | ||||||
PGE2 | 363-24-6 | sc-201225 sc-201225C sc-201225A sc-201225B | 1 mg 5 mg 10 mg 50 mg | $57.00 $159.00 $275.00 $678.00 | 37 | |
Prostaglandin E2 binds to its G protein-coupled receptors, elevating cAMP levels in the cell. This elevation may activate PKA and could subsequently increase C5orf32 activity through phosphorylation mechanisms. | ||||||
Nicotinic Acid | 59-67-6 | sc-205768 sc-205768A | 250 g 500 g | $62.00 $124.00 | 1 | |
This form of vitamin B3 activates G protein-coupled receptors that can lead to increased levels of intracellular cAMP, indirectly activating C5orf32 through PKA-dependent signaling pathways. | ||||||
Dopamine | 51-61-6 | sc-507336 | 1 g | $290.00 | ||
A neurotransmitter that, upon binding to its G protein-coupled receptors, can increase intracellular cAMP levels, indirectly activating C5orf32 through cAMP-dependent PKA signaling. | ||||||
Histamine, free base | 51-45-6 | sc-204000 sc-204000A sc-204000B | 1 g 5 g 25 g | $94.00 $283.00 $988.00 | 7 | |
When interacting with H2 receptors, histamine increases cAMP levels in cells, which may lead to PKA activation. PKA can phosphorylate various substrates, potentially leading to the activation of C5orf32. | ||||||
Anisomycin | 22862-76-6 | sc-3524 sc-3524A | 5 mg 50 mg | $99.00 $259.00 | 36 | |
Acts as a protein synthesis inhibitor. It activates stress-activated protein kinases (SAPKs), which could potentially phosphorylate and activate C5orf32 as part of a stress response. | ||||||
Rolipram | 61413-54-5 | sc-3563 sc-3563A | 5 mg 50 mg | $77.00 $216.00 | 18 | |
A selective inhibitor of phosphodiesterase 4 (PDE4), which increases cAMP levels by preventing its breakdown. Elevated cAMP may lead to PKA activation and subsequent phosphorylation and activation of C5orf32. | ||||||
L-Arginine | 74-79-3 | sc-391657B sc-391657 sc-391657A sc-391657C sc-391657D | 5 g 25 g 100 g 500 g 1 kg | $20.00 $31.00 $61.00 $219.00 $352.00 | 2 | |
A precursor for nitric oxide synthesis, which can activate guanylate cyclase and increase intracellular cGMP levels. This may lead to cross-activation of cAMP pathways and activation of PKA, indirectly leading to C5orf32 activation. | ||||||